Page last updated: 2024-09-04

cyc 202 and mefenamic acid

cyc 202 has been researched along with mefenamic acid in 1 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(mefenamic acid)
Trials
(mefenamic acid)
Recent Studies (post-2010) (mefenamic acid)
97973931,180158267

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)mefenamic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)1.6
MyeloperoxidaseHomo sapiens (human)1.595
Prostaglandin G/H synthase 1Homo sapiens (human)0.116
Prostaglandin G/H synthase 2Homo sapiens (human)1.751
Aldo-keto reductase family 1 member C3Homo sapiens (human)0.56
Aldo-keto reductase family 1 member C2 Homo sapiens (human)6.97
Aldo-keto reductase family 1 member C1Homo sapiens (human)3.91

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1

Other Studies

1 other study(ies) available for cyc 202 and mefenamic acid

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010